Evrofarma SA (ATH:EVROF)
Greece · Delayed Price · Currency is EUR 3.970
+0.100 (2.58%)
May 29, 2026, 5:10 PM EET
Evrofarma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 49.44 | 45.72 | 48.76 | 45.38 | 36.7 | |
Revenue Growth (YoY) | 8.14% | -6.24% | 7.45% | 23.66% | 8.23% |
Cost of Revenue | 38.92 | 36.99 | 41.7 | 39.59 | 32.86 |
Gross Profit | 10.52 | 8.73 | 7.06 | 5.8 | 3.84 |
Selling, General & Admin | 6.83 | 6.09 | 4.64 | 4.69 | 4.73 |
Other Operating Expenses | -0.9 | -1.09 | -1.24 | -1.15 | -1.12 |
Operating Expenses | 5.93 | 5 | 3.4 | 3.54 | 3.61 |
Operating Income | 4.6 | 3.73 | 3.66 | 2.26 | 0.23 |
Interest Expense | -0.65 | -1.1 | -1.32 | -0.84 | -0.78 |
Interest & Investment Income | 0.04 | - | - | - | - |
Earnings From Equity Investments | - | - | 0.06 | 0.02 | 0.03 |
Other Non Operating Income (Expenses) | -0.09 | -0.09 | -0.07 | -0.07 | -0.01 |
EBT Excluding Unusual Items | 3.9 | 2.54 | 2.32 | 1.36 | -0.54 |
Gain (Loss) on Sale of Investments | - | 0 | -0 | - | -0.02 |
Gain (Loss) on Sale of Assets | 0.05 | 0.02 | - | - | 0 |
Asset Writedown | 0.58 | 0.33 | 0.39 | 0.16 | 0.3 |
Pretax Income | 4.53 | 2.89 | 2.71 | 1.52 | -0.26 |
Income Tax Expense | 1 | 0.61 | 0.51 | 0.1 | 0.1 |
Net Income | 3.53 | 2.28 | 2.2 | 1.42 | -0.36 |
Net Income to Common | 3.53 | 2.28 | 2.2 | 1.42 | -0.36 |
Net Income Growth | 54.65% | 3.54% | 55.18% | - | - |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | -0.00% | -0.03% | 0.05% | -0.02% | - |
EPS (Basic) | 0.26 | 0.17 | 0.16 | 0.10 | -0.03 |
EPS (Diluted) | 0.26 | 0.17 | 0.16 | 0.10 | -0.03 |
EPS Growth | 54.65% | 3.57% | 55.11% | - | - |
Free Cash Flow | -0.51 | 4.13 | 0.53 | 0.6 | -4.15 |
Free Cash Flow Per Share | -0.04 | 0.30 | 0.04 | 0.04 | -0.30 |
Dividend Per Share | 0.060 | 0.050 | 0.050 | - | - |
Dividend Growth | 20.00% | - | - | - | - |
Gross Margin | 21.29% | 19.10% | 14.48% | 12.77% | 10.46% |
Operating Margin | 9.29% | 8.15% | 7.50% | 4.97% | 0.63% |
Profit Margin | 7.13% | 4.99% | 4.52% | 3.13% | -0.97% |
Free Cash Flow Margin | -1.03% | 9.03% | 1.09% | 1.32% | -11.31% |
EBITDA | 6.54 | 5.49 | 5.31 | 3.75 | 1.63 |
EBITDA Margin | 13.24% | 12.02% | 10.89% | 8.26% | 4.45% |
D&A For EBITDA | 1.95 | 1.77 | 1.66 | 1.49 | 1.4 |
EBIT | 4.6 | 3.73 | 3.66 | 2.26 | 0.23 |
EBIT Margin | 9.29% | 8.15% | 7.50% | 4.97% | 0.63% |
Effective Tax Rate | 22.10% | 21.05% | 18.66% | 6.77% | - |
Advertising Expenses | 0.25 | 0.2 | 0.17 | 0.16 | 0.12 |